2010 report posted for filing Botox maker to pay $600M to resolve investigation By MATTHEW PERRONE, AP Health Writer Matthew Perrone, Ap Health Writer Thu Sep 2, 4:01 am ET WASHINGTON – Allergan Inc., the maker… Read More ›
Off-label use
Only 15% of Whistleblower Off Label Drug Complaints have Adequate Financial Disclosure
Contact: Sumrina Yousufzai syousufzai@plos.org 415-568-3164 Public Library of Science COI declarations and off-label drug use Conflict-of-interest statements made by physicians and scientists in their medical journal articles after they had been allegedly paid by pharmaceutical manufacturers as part of off-label… Read More ›
Dangerous experiment in fetal engineering (MUST READ)
Public release date: 2-Aug-2012 Dangerous experiment in fetal engineering Risky prenatal use of steroid to try to prevent intersex, tomboys and lesbians CHICAGO — A new paper just published in the Journal of Bioethical Inquiry uses extensive Freedom of Information… Read More ›
Engineering Evil 